CA
NZ
UK
AU
IND
US
Provectus Biopharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 10, 2026, disclosing a net loss of $3,563,375 for the nine months ended September 30, 2026.
An officer and director of MPLX LP filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 3,512 common units with an aggregate market value of $199,270.88 through Fidelity Brokerage Services LLC on the New York Stock Exchange.
Invesco Ltd. filed Amendment No. 2 to a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 8,371,170 American Depositary Receipts of Canaan Inc as of September 30, 2026.
Coastlands Capital LP filed a Form 4 with the SEC on November 10, 2026, disclosing a purchase of 50,000 shares of common stock in Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) on November 9, 2026.
Curaleaf Holdings, Inc. filed a current report on November 10, 2026, disclosing that the company has received all required competition law clearances for its proposed acquisition of Aurora Cannabis.
Quantinuum (NASDAQ:QNT) and RIKEN announced on November 10, 2026 an expansion of their collaboration, anchored by the successful upgrade of the Reimei quantum computer at RIKEN to Quantinuum's H2 system, and including a new three-party agreement with SoftBank Corp. to explore connecting quantum computers …
Daniel M. Sessa, EVP and Chief HR Officer of Lennox International Inc (NYSE:LII), filed a Form 4 on November 10, 2026, reporting three transactions in company common stock on November 9, 2026, including the exercise of non-qualified Stock Appreciation Rights and subsequent share dispositions.
Great Point Capital LLC filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 1,784,236 Class A Ordinary Shares of Renatus Tactical Acquisition Corp I as of September 30, 2026.
Invesco Ltd. filed an amended Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 2,191,008 shares of ArcBest Corp common stock, representing 9.8% of the class, as of September 30, 2026.
Invesco Ltd. filed an amended Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 3,507,236 shares of Atmus Filtration Technologies Inc common stock as of September 30, 2026.
Please wait processing your request...